FireEye Announces Participation in Upcoming Investor Conferences

MILPITAS, CA -- (Marketwired) -- 09/06/16 -- FireEye, Inc. (NASDAQ: FEYE), the leader at stopping today's advanced cyber attacks, today announced participation in upcoming conferences.

• Citi 2016 Global Technology Conference New York, NY Presentation: Wednesday, September 7, 2016 at 3:20 p.m. EDT

• Deutsche Bank 2016 Technology Conference Las Vegas, NV Presentation: Wednesday, September 14, 2016 at 10:20 a.m. PDT

The above presentations will be webcast. Links to the live and archived webcasts will be available from the investor relations section of the company's website at http://investors.fireeye.com/events.cfm.

About FireEye, Inc. FireEye has invented a purpose-built, virtual machine-based security platform that provides real-time threat protection to enterprises and governments worldwide against the next generation of cyber attacks. These highly sophisticated cyber attacks easily circumvent traditional signature-based defenses, such as next-generation firewalls, IPS, anti-virus, and gateways. The FireEye Threat Prevention Platform provides real-time, dynamic threat protection without the use of signatures to protect an organization across the primary threat vectors and across the different stages of an attack life cycle. The core of the FireEye platform is a virtual execution engine, complemented by dynamic threat intelligence, to identify and block cyber attacks in real time. FireEye has over 5,000 customers across 67 countries, including more than 940 of the Forbes Global 2000

© 2016 FireEye, Inc. All rights reserved. FireEye is a registered trademark of FireEye, Inc. in the United States and other countries.

Source: FireEye

You May Also Be Interested In

• Antengene Announces 2026 Interim Results: Achieves First‑Ever Profitability and Accelerates Value Creation Through Innovative R&D
• Anbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion
• Additional Information on the Ehrmann Family Increasing Its Equity Stake in Artprice by Artmarket as Part of Artprice's "AI-First" Transformation